Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL1706 + SOX in Locally Advanced Diffuse-Type Gastric Adenocarcinoma
NCT07315035Phase 2Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jan 2026
- Primary completion
- Dec 2028
- Modality
- Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of QL1706 in gastric adenocarcinoma, sponsored by Jiangsu Provincial People's Hospital. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
QL1706
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT07315035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07315035.